| INTRODUC TI ON
Excessive fibrosis underlies many critical organ dysfunctions. 1, 2 Fibrosis emanates from fibroblast trans-differentiation into myofibroblasts, 3 marked by increased α-smooth muscle actin (α-SMA) expression and excessive collagen secretion, initiated as a reparative process of normal wound healing and tissue repair in response to injury. 4 However, activated myofibroblasts accumulate within pathological lesions of various fibrotic disorders, 5 including patchy and interstitial fibrosis in progressive heart failure and cardiac hypertrophy. 6 Therefore, attenuation of differentiation to myofibroblasts is expected to mitigate fibrosis. We attempted to find a potential target to extenuate the fibroblast differentiation by analysing the transcription factors in human fibroblasts/myofibroblasts, as transcriptome changes occur in fibroblasts during differentiation. 7 Here, we report a novel molecular target, transcription factor AP-2α (TFAP2A), to reduce fibroblasts trans-differentiation. 
| MATERIAL S AND ME THODS

| Polymerase chain reaction array
The isolated hVFs were grouped into fibroblasts-less differentiated (HF-LD) and fibroblasts-highly differentiated (HF-HD) based on their α-SMA expression (immunoblot), compared to the control hVFs ( Figure 1A ,B). Polymerase chain reaction (PCR) array was performed with RT 2 Profiler™ PCR Array-Human Transcription
Factors and compared between HF-LD (n = 3) and HF-HD (n = 3).
Mature RNA (miRNeasy Mini kit) was reverse transcribed using based on a Manual Selection of reference genes. The fold change/ regulation (2^(-ΔΔC T )) was calculated using ΔΔC T method [ΔC T was calculated between target gene and an average of reference genes (HKG), followed by ΔΔC T calculations (ΔC T (Test Group)-
| Quantitative real-time PCR
Total RNA was isolated from hVFs (miRNeasy Mini kit) and reverse tran- 
| CRISPR/CAS9-based deletion of TFAP2A gene
The TFAP2A knockout cell line with NIH/3T3 fibroblasts (TFAP2A-
KO) was established using CRISPR/CAS9 technology through
Creative Biogene, Shirley, NY.
| In vitro trans-differentiation protocol
Fibroblasts from wild-type or TFAP2A-KO groups were plated at 4000 cells/cm 2 with DMEM media (10% BCS) and incubated at 37°C under 5%CO 2 . Following 24 hours, hVFs were either treated with TGF-β1 (5 ng/mL), angiotensin II (100 nM) or kept as control in DMEM media (2.5% BCS). After 48-72 hours, the fibroblasts/myofibroblasts were rinsed with Dulbecco's PBS and assayed.
| Immunoblotting
Standard western protocols were followed 8 with respective primary (dilutions: α-SMA, 1:500, TFAP2A, 1:100) and secondary antibodies (1:2000). All samples were immunoblotted simultaneously and repeated at least twice.
| Proliferation
Both WT and KO fibroblasts were plated as stated before in tripli- 
| RE SULTS AND D ISCUSS I ON
From left ventricle of human heart, fibroblasts were isolated and grouped into less differentiated (HF-LD) and highly differentiated (HF-HD) based on their α-SMA expression, compared to control hVFs as shown in Figure 1A ,B. PCR array of human transcription factors uncovered that the TFAP2A expression, along with ELK1, was decreased with decrease in differentiation as visualized in the heat map ( Figure 1C ) and fold regulation data ( Figure 1D) (n = 3). This decreased expression of TFAP2A in HF-LD fibroblasts compared to HF-HD myofibroblasts noticed in PCR array was validated by quantitative reverse transcriptase-PCR (n = 5) ( Figure 1E ). Based on these data, we have suggested that TFAP2A
is crucial for the trans-differentiation of fibroblasts into myofibroblasts. We applied CRISPR/Cas9-based gene editing to knockout TFAP2A from NIH/3T3 fibroblasts ( Figure 2A) various genes and complete knockout of which is embryonically lethal. 10 The exact mechanism for the reduced trans-differentiation of TFAP2A-KO fibroblasts in response to TGF-β1 is unclear. 
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